• On May 15, 2026, Trillium Asset Management filed an exempt solicitation urging Target shareholders to vote against Executive Chair Brian Cornell and Lead Independent Director Christine Leahy at the June 10 annual meeting, citing concerns over leadership and prior decisions.
• At the same time, Target is broadening its wellness, functional food, and men’s personal care offerings through new exclusive and nationwide brand launches, underscoring a push to refresh in-store assortments while governance tensions rise.
• With activist pressure intensifying around board leadership, we’ll now examine how this challenge could reshape Target’s existing investment narrative.

Uncover the next big thing with 25 elite penny stocks that balance risk and reward.

Target Investment Narrative Recap

To own Target today, you need to believe its store remodels, merchandising reset, and omnichannel investments can translate into steadier earnings, even as consumer sentiment and discretionary spending remain under pressure. The most important near term catalyst is clear proof of merchandising and traffic improvement, particularly around the upcoming earnings and store refreshes. Trillium’s campaign against board leadership adds governance noise, but unless it leads to board or strategy changes, it does not yet alter that core catalyst or the key risk of an incomplete turnaround.

Against this backdrop, Target’s recent push into wellness, functional food, and men’s personal care through brands like RYZE, Seven Sundays, Ready Protein Bars, and Onside is especially relevant. These launches highlight how management is trying to reposition in growth areas that can support frequency and margin, complementing store remodels and digital investments. Whether these newer assortments genuinely change the earnings trajectory will be an important proof point alongside the activist pressure now building.

But while new wellness brands and store upgrades may sound encouraging, investors should also be aware of the growing scrutiny around board leadership and...

Target’s narrative projects $110.5 billion revenue and $3.7 billion earnings by 2028. This assumes revenue grows 1.4% per year, with earnings declining by $0.5 billion from $4.2 billion today.

Uncover how Target's forecasts yield a $96.52 fair value, a 21% downside to its current price.

Exploring Other Perspectives

Some of the most optimistic analysts were expecting Target’s revenues to reach about US$117.6 billion and earnings around US$4.2 billion, yet the latest governance challenge and concerns about costly digital adaptation show how far views can diverge from those pre news assumptions and why you should compare multiple narratives before deciding what you believe.

Explore 16 other fair value estimates on Target - why the stock might be worth 29% less than the current price!

Reach Your Own Conclusion

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your Target research is our analysis highlighting 4 key rewards and 2 important warning signs that could impact your investment decision.
• Our free Target research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Target's overall financial health at a glance.

Want Some Alternatives?

Don't miss your shot at the next 10-bagger. Our latest stock picks just dropped:

• The future of work is here. Discover the 30 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
• We've uncovered the 12 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.
• This technology could replace computers: discover 26 stocks that are working to make quantum computing a reality.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.